Stuart Chalew
Pediatric Endocrinology · New Orleans, LANPI 1558384594
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,340 of the $6,908 with a category attached, or 62.8%. Medtronic accounts for 66.0% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $3,390 and has fallen 90.0% since, to $340 in 2025.
Across 103 payments — averaging $67.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Novo Nordisk$474
- Ascendis Pharma Endocrinology Inc$264
- AbbVie$164
- Mannkind Corporation$164
- Dexcom, Inc.$155
- plus $1K from 19 others
Across 15 payments — averaging $2527.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$27K
- Eli Lilly$11K
- Merck$92
What the payments were for
- Speaking & faculty fees$4,34063%
- Food & beverage$2,49936%
- Education$691%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 11 | $4,562 |
| Novo Nordisk | 16 | $474 |
| Ascendis Pharma Endocrinology Inc | 7 | $264 |
| AbbVie | 9 | $164 |
| Mannkind Corporation | 1 | $164 |
| Dexcom, Inc. | 5 | $155 |
| Ultragenyx Pharmaceutical Inc. | 6 | $134 |
| Lilly USA, LLC | 7 | $118 |
| Kyowa Kirin, Inc. | 1 | $110 |
| Pfizer | 5 | $108 |
| Arbor Pharmaceuticals, Inc. | 5 | $84 |
| Endo Pharmaceuticals Inc. | 5 | $83 |
| AstraZeneca | 3 | $77 |
| Tolmar Pharmaceuticals, Inc. | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 3 | $56 |
| Azurity Pharmaceuticals, Inc. | 3 | $52 |
| BETA Bionics, Inc. | 3 | $39 |
| Abbott | 2 | $37 |
| Insulet Corporation | 2 | $33 |
| Zealand Pharma US, Inc. | 1 | $27 |
| Chiesi USA, Inc. | 1 | $27 |
| Biomarin Pharmaceutical Inc. | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric endocrinology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in New Orleans
- Ricardo GomezNew Orleans$6K
- Cielo AlleynNew Orleans$3K
- Dania Felipe-RamirezNew Orleans$3K
- Arlette Soros DupreNew Orleans$2K
- Carmen MironoviciNew Orleans$923
- Aqeel AlaqeelNew Orleans$131
- Alfonso Vargas-Del ValleNew Orleans$23
- Janna Flint WilsonLafayette$5K
- Sasi PenukondaShreveport$2K
- Chantal LutfallahBaton Rouge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.